Related Experiment Videos
Therapy for pneumococcal bacteremia: monotherapy or combination therapy?
Charles Feldman1, Ronald Anderson
1Division of Pulmonology, Department of Medicine, Johannesburg Hospital and Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parkdown, Johannesburg, South Africa. charles.feldman@wits.ac.za
Current Opinion in Infectious Diseases
|March 12, 2009
Summary
The use of combination antibiotic therapy for bacteremic pneumococcal infections remains unresolved. Recent studies show mixed results, with some suggesting benefits in severe cases but not consistently in less severe community-acquired pneumonia.
Area of Science:
- Infectious Diseases
- Pharmacology
- Critical Care Medicine
Background:
- Bacteremic pneumococcal infections pose a significant health challenge.
- The optimal antibiotic strategy, monotherapy versus combination therapy, is debated.
- Recent research aims to clarify treatment efficacy.
Purpose of the Study:
- To review recent studies addressing combination antibiotic therapy for bacteremic pneumococcal infections.
- To evaluate the effectiveness of combination therapy compared to monotherapy.
- To explore potential mechanisms underlying treatment outcomes.
Main Methods:
- Literature review of recent clinical studies and investigations.
- Analysis of treatment outcomes in patients with community-acquired pneumonia and bacteremic pneumococcal infections.
- Examination of studies exploring mechanisms of action for combination therapy.
Main Results:
- Combination therapy may benefit severely ill patients with community-acquired pneumonia.
- Monotherapy (fluoroquinolone) was as effective as combination therapy in less severe cases.
- Studies on bacteremic pneumococcal pneumonia specifically did not consistently show combination therapy benefits.
- Guideline-compliant therapy, often beta-lactam/macrolide combinations, is associated with favorable outcomes globally.
Conclusions:
- The definitive role of combination antibiotic therapy for bacteremic pneumococcal infections is still not resolved.
- Evidence remains conflicting regarding its superiority over monotherapy in all patient groups.
- Further research is needed to establish clear treatment guidelines.
Related Concept Videos
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: